Past performance does not equate to future performance in the stock market. You can research stocks of similar characteristics ....60 million is not unusual at all neither is 600 million. NWB* is 146 mill with 1 drug in testing or (7 cents based on our share structure) it has no over the counter drugs and no other patents that I can see...there are lots of other examples. I have another one that is struggling and I sold out until the Feds reclassify, the "drugs" will never be able to be sold on the GSA to the Vets etc etc etc. BTW Pet Pain Away is back ordered....Im quite sure Nyloxin sales have jumped just from my circle !~